The Twenty Minute VC - Bryan Johnson @ OS Fund & Braintree

Investing in Operating Systems of life & open source VC

Discussion
Would you recommend this product?
No reviews yet
@bryan_johnson is an entrepreneur and investor. He is the founder of OS Fund and Braintree, the latter of which was bought by eBay in 2013 for $800 million in cash. Bryan launched OS Fund in 2014 with $100 million of his personal capital to support inventors and scientists who aim to benefit humanity. His investments include endeavors to extend healthy human life to 100+ (Human Longevity), replicate the human visual cortex (Vicarious), mine an asteroid (Planetary Resources), reinvent transportation (Matternet), and reimagine food (Hampton Creek), among others. A special thank you to Mattermark for providing all the data displayed in today's show and you can find out more about Mattermark here! In Today's Episode You Will Learn: 1.) How Bryan made his start in the world of tech and how he has come to the OS fund today? 2.) What was the pivotal moment in Bryan's career? When was the turning point? What was was the hardest part of the entrepreneurial journey and how did Bryan conquer it? 3.) What is the main motivation behind the OS fund? Which areas does Bryan most want to solve and where does he see significant market opportunities? 4.) Does the longevity of return to Bryan's exits concern him? Most investments exit with 10 years, human lifespan startups take a little longer! What sort of time frame does Bryan have in mind when investing in these companies? 5.) What does Bryan really perceive synthetic biology to mean? Are we seeing improvements in this sector? 6.) The OS Fund have recently released a white paper detailing extensively their process for investing? Why did Bryan decide on this open source style of investing? 7.) What would Bryan like to see more of? Where does Bryan see a lot of people investing that he thinks is a mistake? Items Mentioned In Today's Episode: Bryan's Fave Book: Endurance: Shackleton’s Incredible Voyage to the Antarctic Bryan's Most Recent Investment: Ginkgo Bioworks